{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:06:01Z","timestamp":1790125561525,"version":"4.0.1"},"reference-count":100,"publisher":"Centers for Disease Control MMWR Office","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr6703a1","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T15:15:35Z","timestamp":1535037335000},"page":"1-20","source":"Crossref","is-referenced-by-count":347,"title":["Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2018\u201319 Influenza Season"],"prefix":"10.15585","volume":"67","author":[{"given":"Lisa A.","family":"Grohskopf","sequence":"first","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Z.","family":"Sokolow","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, CDC"},{"name":"Battelle Memorial Institute, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Broder","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel B.","family":"Walter","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Fry","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Jernigan","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2105\/AJPH.76.7.761","article-title":"Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970\u201378.","volume":"76","author":"Barker","year":"1986","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/oxfordjournals.aje.a113052","article-title":"Impact of epidemic type A influenza in a defined adult population.","volume":"112","author":"Barker","year":"1980","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1542\/peds.2012-1255","article-title":"The burden of influenza in young children, 2004\u20132009.","volume":"131","author":"Poehling","year":"2013","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children.","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.vaccine.2006.09.041","article-title":"Influenza- and RSV-associated hospitalizations among adults.","volume":"25","author":"Mullooly","year":"2007","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R7","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2017\u201318 influenza season.","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R9","unstructured":"Advisory Committee on Immunization Practices. Summary report: February 24, 2016 (Meeting minutes). Atlanta, GA: US Department of Health and Human Services, CDC; 2016."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jaip.2014.08.008","article-title":"Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine.","volume":"3","author":"Des Roches","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R11","doi-asserted-by":"publisher","first-page":"h6291","DOI":"10.1136\/bmj.h6291","article-title":"Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study.","volume":"351","author":"Turner","year":"2015","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jaci.2014.12.1925","article-title":"Safety of live attenuated influenza vaccine in atopic children with egg allergy.","volume":"136","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R13","unstructured":"CDC. The flu season. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https:\/\/www.cdc.gov\/flu\/about\/season\/flu-season.htm"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R14","doi-asserted-by":"publisher","first-page":"20388","DOI":"10.2807\/ese.18.05.20388-en","article-title":"Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011\/12.","volume":"18","author":"Castilla","year":"2013","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.vaccine.2014.06.052","article-title":"Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season.","volume":"33","author":"Belongia","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/cid\/ciw816","article-title":"Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011\u201312 through 2014\u201315.","volume":"64","author":"Ferdinands","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R17","doi-asserted-by":"publisher","first-page":"20390","DOI":"10.2807\/ese.18.05.20390-en","article-title":"Low and decreasing vaccine effectiveness against influenza A(H3) in 2011\/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.","volume":"18","author":"Kissling","year":"2013","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R18","doi-asserted-by":"publisher","first-page":"20389","DOI":"10.2807\/ese.18.05.20389-en","article-title":"Vaccine effectiveness of 2011\/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.","volume":"18","author":"Pebody","year":"2013","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R19","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1016\/j.vaccine.2017.09.035","article-title":"Waning protection of influenza vaccination during four influenza seasons, 2011\/2012 to 2014\/2015.","volume":"35","author":"Puig-Barber\u00e0","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R20","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1016\/j.vaccine.2016.05.034","article-title":"Influenza vaccine effectiveness: maintained protection throughout the duration of influenza seasons 2010\u20132011 through 2013\u20132014.","volume":"34","author":"Radin","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R21","article-title":"I-MOVE multicentre case-control study 2010\/11 to 2014\/15: is there within-season waning of influenza type\/subtype vaccine effectiveness with increasing time since vaccination?","volume":"21","author":"Kissling","year":"2016","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/infdis\/jiw105","article-title":"Modest waning of influenza vaccine efficacy and antibody titers during the 2007\u20132008 influenza season.","volume":"214","author":"Petrie","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R23","first-page":"1","article-title":". Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R24","first-page":"1","article-title":"Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Pearson","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R25","doi-asserted-by":"publisher","first-page":"S731","DOI":"10.1093\/infdis\/136.Supplement_3.S731","article-title":"Trials of influenza A\/New Jersey\/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity.","volume":"136","author":"Wright","year":"1977","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/infdis\/134.6.633","article-title":"Summary of clinical trials of influenza vaccines\u2014II.","volume":"134","author":"Wright","year":"1976","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0022-3476(76)80722-6","article-title":"Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants.","volume":"88","author":"Wright","year":"1976","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R28","doi-asserted-by":"publisher","first-page":"S616","DOI":"10.1093\/infdis\/136.Supplement_3.S616","article-title":"Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children: a summary.","volume":"136","author":"Gross","year":"1977","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1542\/peds.69.4.404","article-title":"Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.","volume":"69","author":"Bernstein","year":"1982","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R30","first-page":"9","article-title":"Time to change dosing of inactivated quadrivalent influenza vaccine in young children: evidence from a Phase III, randomized, controlled trial.","volume":"6","author":"Jain","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1086\/507309","article-title":"Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5\u20138-year-old children.","volume":"194","author":"Neuzil","year":"2006","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jpeds.2006.06.036","article-title":"Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003\u20132004 season.","volume":"149","author":"Allison","year":"2006","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1542\/peds.2005-0049","article-title":"Effectiveness of the 2003\u20132004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses.","volume":"116","author":"Ritzwoller","year":"2005","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R34","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1542\/peds.2007-3304","article-title":"Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003\u20132004 and 2004\u20132005 influenza seasons.","volume":"122","author":"Eisenberg","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R35","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1097\/AOG.0000000000002588","article-title":"ACOG Committee Opinion No. 732. Influenza vaccination during pregnancy.","volume":"131","author":"ACOG Committee on Obstetric Practice","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R36","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/AOG.0000000000002586","article-title":"ACOG Committee Opinion No. 732. Mummary: influenza vaccination during pregnancy.","volume":"131","author":"ACOG Committee on Obstetric Practice","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R37","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002665","article-title":"ACOG Committee Opinion No. 741. Maternal immunization.","volume":"131","author":"ACOG Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R38","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1016\/j.vaccine.2017.06.069","article-title":"Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010\u201311 and 2011\u201312.","volume":"35","author":"Donahue","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R39","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1016\/j.vaccine.2016.06.054","article-title":"Safety of the 2010\u201311, 2011\u201312, 2012\u201313, and 2013\u201314 seasonal influenza vaccines in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.","volume":"34","author":"Chambers","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R40","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1016\/j.vaccine.2014.09.054","article-title":"Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan.","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R41","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1128\/CVI.00375-14","article-title":"Prospective cohort study of the safety of an influenza A(H1N1) vaccine in pregnant Chinese women.","volume":"21","author":"Ma","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/AOG.0b013e318279f56f","article-title":"Trivalent inactivated influenza vaccine and spontaneous abortion.","volume":"121","author":"Irving","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R43","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1016\/j.vaccine.2013.08.097","article-title":"Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.","volume":"31","author":"Chambers","year":"2013","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R44","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1016\/j.vaccine.2012.04.081","article-title":"A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy.","volume":"30","author":"Oppermann","year":"2012","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R45","doi-asserted-by":"publisher","first-page":"e2794","DOI":"10.1136\/bmj.e2794","article-title":"Vaccination against pandemic A\/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.","volume":"344","author":"Pasternak","year":"2012","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R46","doi-asserted-by":"publisher","first-page":"e51734","DOI":"10.1371\/journal.pone.0051734","article-title":"Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD.","volume":"7","author":"Sammon","year":"2012","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R47","doi-asserted-by":"crossref","unstructured":"Heikkinen T, Young J, van Beek E, Safety of MF59-adjuvanted A\/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012;207:177 e1\u20138.","DOI":"10.1016\/j.ajog.2012.07.007"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R48","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.vaccine.2015.02.068","article-title":"Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes.","volume":"33","author":"McMillan","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R49","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1093\/cid\/ciu915","article-title":"Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis.","volume":"60","author":"Bratton","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R50","unstructured":"Advisory Committee on Immunization Practices. Summary report: October 25\u201326, 2017 (Meeting minutes). Atlanta, GA: US Department of Health and Human Services, CDC; 2017."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R51","unstructured":"FluLaval Quadrivalent [Package Insert]. Quebec City, Quebec, Canada: ID Biomedical Corporation of Quebec; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R52","unstructured":"Fluarix Quadrivalent [Package Insert]. Research Triangle Park, North Carolina: GlaxoSmithKline; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R53","unstructured":"Afluria Quadrivalent [Package Insert]. Parkville, Victoria, Australia: Seqirus; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R54","unstructured":"Flucelvax Quadrivalent [Package Insert]. Holly Springs, NC: Seqirus; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R55","unstructured":"Flublok Quadrivalent [Package Insert]. Swiftwater, PA: Sanofi Pasteur; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R56","unstructured":"Fluzone Quadrivalent. Swiftwater, PA: Sanofi Pasteur; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults.","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R58","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1016\/j.vaccine.2015.07.006","article-title":"Prevention of serious events in adults 65 years of age or older: a comparison between high-dose and standard-dose inactivated influenza vaccines.","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R59","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa1608862","article-title":"Efficacy of recombinant influenza vaccine in adults 50 years of age or older.","volume":"376","author":"Dunkle","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R60","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1016\/j.vaccine.2013.07.059","article-title":"The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly.","volume":"31","author":"Van Buynder","year":"2013","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R61","unstructured":"Clinical Review: Fluad. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2014."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.","volume":"200","author":"Falsey","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R63","unstructured":"Fluzone High-Dose [Package Insert]. Swiftwater, PA: Sanofi Pasetur; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R64","unstructured":"Food and Drug Administration. October 29, 2014 clinical review\u2014Fluzone High-Dose. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2014."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R65","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(17)30235-7","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial.","volume":"5","author":"Gravenstein","year":"2017","journal-title":"Lancet Respir Med"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R66","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/infdis\/jiy088","article-title":"Relative vaccine effectiveness of high-dose versus standard-dose influenza vaccines among Veterans Health Administration patients.","volume":"217","author":"Young-Xu","year":"2018","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R67","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/cid\/civ261","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.","volume":"61","author":"Richardson","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R68","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/infdis\/jiw641","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries in preventing postinfluenza deaths during 2012\u20132013 and 2013\u20132014.","volume":"215","author":"Shay","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1473-3099(14)71087-4","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.","volume":"15","author":"Izurieta","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14760584.2018.1471989","article-title":"Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis.","volume":"17","author":"Lee","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R71","unstructured":"Food and Drug Administration. Summary basis for regulatory action\u2014Flublok Quadrivalent. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2016."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R72","unstructured":"Kroger AT, Duchin J, V\u00e1zquez M. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/downloads\/general-recs.pdf"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R73","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R74","unstructured":"CDC. Antiviral drugs: information for healthcare professionals. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/index.htm"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R75","doi-asserted-by":"publisher","first-page":"b3680","DOI":"10.1136\/bmj.b3680","article-title":"Recommendations for the administration of influenza vaccine in children allergic to egg.","volume":"339","author":"Erlewyn-Lajeunesse","year":"2009","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R76","unstructured":"CDC. Advisory Committee on Immunization Practices summary report: June 20\u201321, 2012 (meeting minutes). Atlanta, GA: US Department of Health and Human Services, CDC; 2012."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R77","unstructured":"CDC. Advisory Committee on Immunization Practices summary report: June 19\u201320, 2013 (meeting minutes). Atlanta, GA: US Department of Health and Human Services, CDC; 2013."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1086\/313974","article-title":"Cruise ships: high-risk passengers and the global spread of new influenza viruses.","volume":"31","author":"Miller","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R79","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1086\/374053","article-title":"Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory.","volume":"36","author":"Uyeki","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R80","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1086\/429243","article-title":"Influenza virus infection in travelers to tropical and subtropical countries.","volume":"40","author":"Mutsch","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R81","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcv.2013.01.008","article-title":"Incidence and risk factors for acute respiratory illnesses and influenza virus infections in Australian travellers to Asia.","volume":"57","author":"Ratnam","year":"2013","journal-title":"J Clin Virol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R82","unstructured":"Flumist Quadrivalent [Package Insert]. Gaithersburg, Maryland: MedImmune; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R83","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1532-5415.2007.01397.x","article-title":"Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.","volume":"55","author":"Kerzner","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R84","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1128\/CVI.00176-12","article-title":"Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.","volume":"19","author":"Frenck","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R85","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1016\/j.vaccine.2011.05.031","article-title":"A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged \u226565 years.","volume":"29","author":"Schwarz","year":"2011","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R86","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1016\/j.vaccine.2006.12.047","article-title":"Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.","volume":"25","author":"McNeil","year":"2007","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R87","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1016\/j.vaccine.2015.05.003","article-title":"Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults.","volume":"33","author":"Song","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R88","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/AOG.0000000000001066","article-title":"afety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy.","volume":"126","author":"Sukumaran","year":"2015","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamapediatrics.2013.4469","article-title":"Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.","volume":"168","author":"Stockwell","year":"2014","journal-title":"JAMA Pediatr"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R90","doi-asserted-by":"publisher","first-page":"e20160320","DOI":"10.1542\/peds.2016-0320","article-title":"Febrile seizure risk after vaccination in children 6 to 23 months.","volume":"138","author":"Duffy","year":"2016","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R91","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/pds.3996","article-title":"Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013\u20132014 and 2014\u20132015 seasons.","volume":"25","author":"Li","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R92","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.3928\/00904481-20131122-09","article-title":"Febrile seizures.","volume":"42","author":"Patterson","year":"2013","journal-title":"Pediatr Ann"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R93","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1542\/peds.2007-1064","article-title":"Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.","volume":"121","author":"Nolan","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R94","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.vaccine.2009.11.054","article-title":"Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.","volume":"28","author":"Lum","year":"2010","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R95","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/infdis\/jix481","article-title":"Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine coadministered with aged seasonal influenza vaccine in adults 50 years or older.","volume":"216","author":"Schwarz","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R96","unstructured":"Afluria [Package Insert]. Parkville, Victoria, Australia: Seqirus; 2018."},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R97","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/j.vaccine.2017.03.028","article-title":"Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.","volume":"35","author":"Airey","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R98","unstructured":"Clinical Review. (STN: 125127\/834)\u2014Fluarix Quadrivalent. Sliver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2018. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM593001.pdf"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R99","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S2352-4642(18)30062-2","article-title":"Prevention of vaccine-matched and mismatched influenza in children aged 6\u201335 months: a multinational randomized trial across five influenza seasons.","volume":"2","author":"Claeys","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6703a1-201808231117-R100","unstructured":"Health Resources and Services Administration. What you need to know about the National Vaccine Injury Compensation Program (VICP). Washington, DC: US Department of Health and Human Services, Health Resources and Services Administration; 2017."}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T14:08:43Z","timestamp":1751810923000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/67\/rr\/rr6703a1.htm?s_cid=rr6703a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":100,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2018,8,24]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr6703a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,24]]},"published":{"date-parts":[[2018,8,24]]}}}